PRAP:XETRA Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)

EUR 18.09 0.09 0.480449
Icon

Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) (PRAP:XETRA) Stock Analysis and Price Targets

ETF | Others | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 18.09

+0.09 (+0.48)%

EUR 0.09B

2.63K

N/A

N/A

Icon

PRAP:XETRA

Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) (EUR)
ETF | XETRA
EUR 18.09
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.09B

N/A

EUR 18.09

Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) (PRAP:XETRA) Stock Forecast

N/A

Based on the Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) stock forecast from 0 analysts, the average analyst target price for Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) is not available over the next 12 months. Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)’s stock price was EUR 18.09. Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)’s stock price has changed by +0.94% over the past week, +1.45% over the past month and +4.39% over the last year.

No recent analyst target price found for Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)
No recent average analyst rating found for Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)

Company Overview Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)

NA

N/A

0

N/A

EUR

Germany

N/A

N/A

N/A

0.00 %

Adjusted Closing Price for Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) (PRAP:XETRA)

Loading...

Unadjusted Closing Price for Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) (PRAP:XETRA)

Loading...

Share Trading Volume for Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) Shares

Loading...

Compare Performance of Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PRAP:XETRA

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • 3

  • Morningstar US Corp Bd TR USD

  • 3

  • 9.48

  • -2.95

  • -0.56

  • -0.94%

  • 0.90%

  • 0.00%

  • 0%

Stocks Similar To Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) (Sector: Others )

Symbol Name Mer Price(Change) Market Cap
XM1D:XETRA
Xtrackers MSCI Japan UCITS ETF.. 0.00 % -0.09 (-0.17%) EUR441.43B

ETFs Containing PRAP

Symbol Name PRAP's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) (PRAP:XETRA) Stock

Stock Target Advisor's fundamental analysis for Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)'s stock is Bearish.

Unfortunately we do not have enough data on PRAP:XETRA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PRAP:XETRA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on PRAP:XETRA's stock to indicate if its overvalued.

The last closing price of PRAP:XETRA's stock was EUR 18.09.

The most recent market capitalization for PRAP:XETRA is EUR 0.09B.

Unfortunately we do not have enough analyst data on PRAP:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)'s stock.

As per our most recent records Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C) has 0 Employees.

Sorry we do not have any infomation available on Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR (C)'s address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...